Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Article | Year |
Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC.Frontiers in cellular and infection microbiology, 2021, Volume: 11Topics: Animals; Chagas Disease; Cytokines; Fenofibrate; Humans; Leukocytes, Mononuclear; Mice; Monocytes | 2021 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells.Microbial pathogenesis, 2022, Volume: 173, Issue:Pt A
Topics: Chagas Disease; Cyclooxygenase 2; Endothelial Cells; Fenofibrate; Humans; Inflammation; Macrophage M | 2022 |
Macrophages Mediate Healing Properties of Fenofibrate in Experimental Chagasic Cardiomyopathy. | 2023 |
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.International journal for parasitology. Drugs and drug resistance, 2017, Volume: 7, Issue:3
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Diastole; Fenofibrate; Fibrosis; Humans; Inflammatio | 2017 |